ES2191241T3 - Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina. - Google Patents

Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.

Info

Publication number
ES2191241T3
ES2191241T3 ES98119726T ES98119726T ES2191241T3 ES 2191241 T3 ES2191241 T3 ES 2191241T3 ES 98119726 T ES98119726 T ES 98119726T ES 98119726 T ES98119726 T ES 98119726T ES 2191241 T3 ES2191241 T3 ES 2191241T3
Authority
ES
Spain
Prior art keywords
hydroxipropil
cisteine
pharmaceutical preparations
oral route
cysteine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98119726T
Other languages
English (en)
Inventor
Misao Murata
Yukihiro Saito
Hideyoshi Kanbe
Shuji Yamauchi
Akira Iwasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of ES2191241T3 publication Critical patent/ES2191241T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una preparación para administración oral que comprende S-(3-hidroxipropil)-L -cisteína y un excipiente, donde el excipiente es sustancialmente almidón, y una preparación para administración oral que comprende (s-(hidroxipropil)-L-cisteína y una ciclodextrina.
ES98119726T 1997-07-16 1998-10-20 Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina. Expired - Lifetime ES2191241T3 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP19110597A JP4098850B2 (ja) 1997-07-16 1997-07-16 Ｓ−（３−ヒドロキシプロピル）−ｌ−システインを含有する経口用製剤
CA002251297A CA2251297C (en) 1997-07-16 1998-10-19 Oral preparations comprising s-(3-hydroxypropyl)-l-cysteine
EP98119726A EP0998926B1 (en) 1997-07-16 1998-10-20 Oral preparation comprising S-(3-hydroxypropyl)-L-cysteine
US09/176,155 US6441040B1 (en) 1997-07-16 1998-10-21 Oral preparations comprising S-(3-hydroxypropyl)-L-cysteine
KR10-1998-0044204A KR100525128B1 (ko) 1997-07-16 1998-10-21 S-(3-히드록시프로필)-l-시스테인을 함유하는 경구 제제
CNB981226477A CN1155373C (zh) 1997-07-16 1998-11-19 S-(3-羟丙基)-l-半胱氨酸口服制剂组合物

Publications (1)

Publication Number Publication Date
ES2191241T3 true ES2191241T3 (es) 2003-09-01

Family

ID=31999786

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98119726T Expired - Lifetime ES2191241T3 (es) 1997-07-16 1998-10-20 Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.

Country Status (8)

Country Link
US (1) US6441040B1 (es)
EP (1) EP0998926B1 (es)
JP (1) JP4098850B2 (es)
KR (1) KR100525128B1 (es)
CN (1) CN1155373C (es)
CA (1) CA2251297C (es)
DE (1) DE69812962T2 (es)
ES (1) ES2191241T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002096405A1 (en) * 2001-05-25 2002-12-05 Ssp Co., Ltd. Drug preparations
JP3805646B2 (ja) 2001-05-25 2006-08-02 久光メディカル株式会社 医薬液剤
WO2002096406A1 (en) * 2001-05-25 2002-12-05 Ssp Co., Ltd. Medicinal compositions
JP2005298338A (ja) * 2002-02-27 2005-10-27 Eisai Co Ltd 速崩壊性圧縮成形製剤
JP4490668B2 (ja) * 2003-10-23 2010-06-30 田辺三菱製薬株式会社 下痢治療薬
CN100404026C (zh) * 2005-09-23 2008-07-23 北京德众万全药物技术开发有限公司 一种含福多司坦的口服药物组合物
CN102501157A (zh) * 2011-11-21 2012-06-20 长春大学 调压式砂带研磨装置
CN103768011A (zh) * 2012-10-23 2014-05-07 天津药物研究院 福多司坦注射剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187326B1 (es) * 1972-06-15 1975-10-17 Rech Pharm Scientifiques
NL8502092A (nl) * 1985-07-22 1987-02-16 Cedona Haarlemmer Pharma Tabletten die s-carboxymethylcysteine bevatten en werkwijze voor de bereiding daarvan.
JPH0788352B2 (ja) * 1988-06-16 1995-09-27 エスエス製薬株式会社 ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤
KR100304064B1 (ko) * 1993-08-12 2001-11-22 다카하시 미치나오 구강용조성물
US5614197A (en) * 1995-02-13 1997-03-25 Industrial Farmaceutica Cantabria, S.A. Polypodium extract as photoprotectant
EP0799616A1 (en) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative

Also Published As

Publication number Publication date
JPH1135459A (ja) 1999-02-09
EP0998926A1 (en) 2000-05-10
KR20000026603A (ko) 2000-05-15
DE69812962D1 (de) 2003-05-08
CA2251297A1 (en) 2000-04-19
JP4098850B2 (ja) 2008-06-11
CN1254558A (zh) 2000-05-31
CA2251297C (en) 2007-05-29
US6441040B1 (en) 2002-08-27
EP0998926B1 (en) 2003-04-02
DE69812962T2 (de) 2003-12-18
KR100525128B1 (ko) 2005-12-28
CN1155373C (zh) 2004-06-30

Similar Documents

Publication Publication Date Title
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
BR0015188A (pt) Composições farmacêuticas
CO5060503A1 (es) Formulaciones farmaceuticas
ES2157881T3 (es) Metanosulfonato de paroxetina.
NO20014035L (no) System for oral administrasjon av medikament
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
ES2128761T3 (es) Formulacion de tirilazad con cosolvente para administracion parenteral.
ES2119034T3 (es) Preparaciones farmaceuticas de sales de tramadol de liberacion retardada.
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
AR021981A1 (es) Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero
SV2002000137A (es) Productos farmaceuticos beta-carbolina ref n. 29342/36539 el
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
AR011919A1 (es) FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
ES2191241T3 (es) Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.
BR0112847A (pt) Uso de uma forma de dosagem sólida
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
ES2172182T3 (es) Composiciones farmaceuticas que comprenden cefuroxima axetil.
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
ES2184121T3 (es) Formulacion para el tratamiento y/o profilaxis de la demencia.
AR023056A1 (es) Composiciones farmaceuticas basadas en alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh
ATE227997T1 (de) Pharmazeutische zusammensetzung zur nasalen verabreichung von thiocolchicosid
DE59205625D1 (de) Perorale applikationsform für peptidarzneistoffe, insbesondere insulin
HRP20070081T3 (hr) Nazalni farmaceutski pripravak piribedila